INTRODUCTION

Reteplase (brand name Retavase) is a recombinant human tissue plasminogen activator that is used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.

This plasmid is designed for expressing Reteplase in E.coli expression system.

PRODUCT INFORMATION

Item No.: PPBD-158
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Reteplase
Brand Name(s): Retavase
Classification: Thrombolytic agents
Amino Acid Sequence: Identical to DB00015

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Mohammadi E, Seyedhosseini-Ghaheh H, Mahnam K, Jahanian-Najafabadi A, Mir Mohammad Sadeghi H. Reteplase: Structure, Function, and Production. Adv Biomed Res. 2019 Mar 20;8:19.

Contact Us